Back

Medscape, LLC

  • Glomerulonephritis, IGA

A New Chapter in IgA Nephropathy Care: Applying Evidence-Based Practices for B-Cell-Modulating Therapies

The goal of this activity is for learners , including nephrologists and other members of the multidisciplinary team, to be better able to appropriately integrate novel B-cell modulating therapies into IgAN management, in accordance with the latest evidence and clinical practice guidelines.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Aug 24, 2026
  • Last day to claim credit
    Aug 25, 2027 11 months left